Left Menu
Development News Edition

Immune system's T cells play bigger role in reducing COVID-19 severity: Study

"With increasing age, the reservoir of T cells that can be activated against a specific virus declines and the body's immune response becomes less coordinated, which looks to be one factor making older people drastically more susceptible to severe or fatal COVID-19," Crotty said. In the research, the scientists collected blood samples from 50 COVID-19 patients, and analysed multiple branches of their immune system -- novel coronavirus specific antibodies, helper and killer T cells.

PTI | Los Angeles | Updated: 17-09-2020 14:05 IST | Created: 17-09-2020 13:47 IST
Immune system's T cells play bigger role in reducing COVID-19 severity: Study
Representative image Image Credit: ANI

Vaccine candidates for COVID-19 should elicit a broad immune response that includes antibodies, and the body's helper and killer T cells, according to a study which says weak or uncoordinated immunity may lead to a poor disease outcome. The research, published in the journal Cell, confirms that a multi-layered, virus-specific immune response is important for controlling the novel coronavirus during the acute phase of the infection and reducing COVID-19 disease severity. "Our observations could also explain why older COVID-19 patients are much more vulnerable to the disease," said study senior author Shane Crotty from the La Jolla Institute for Immunology in the US. "With increasing age, the reservoir of T cells that can be activated against a specific virus declines and the body's immune response becomes less coordinated, which looks to be one factor making older people drastically more susceptible to severe or fatal COVID-19," Crotty said.

In the research, the scientists collected blood samples from 50 COVID-19 patients, and analysed multiple branches of their immune system -- novel coronavirus specific antibodies, helper and killer T cells. "It was particularly important to us to capture the whole range of disease manifestation from mild to critically ill so we could identify differentiating immunological factors," said study co-author and infectious disease specialist Sydney Ramirez.

The researchers found that all fully recovered individuals had measurable antibody, helper and killer T cell responses against the novel coronavirus SARS-CoV-2. However, they said the response varied widely in acute COVID-19 patients, with some lacking neutralising antibodies, others helper or killer T cells or any combination thereof. "When we looked at a combination of all of our data across all 111 measured parameters we found that in general, people who mounted a broader and well-coordinated adaptive response tended to do better," said Carolyn Moderbacher, another co-author of the study from La Jolla Institute for Immunology. "A strong SARS-CoV-2 specific T cell response, in particular, was predictive of milder disease. Individuals whose immune response was less coordinated tended to have poorer outcomes," Moderbacher said.

The scientists found that the effect was magnified when they broke down the dataset by age. "People over the age of 65 were much more likely to have poor T cell responses, and a poorly coordinated immune response, and thus have much more severe or fatal COVID-19," Crotty said. The scientists explained that as people age, the immune system's supply of deployable immature T cells dwindles, with fewer cells available to be activated to respond to a new virus. "This could either lead to a delayed adaptive immune response that is unable to control a virus until it is too late to limit disease severity or the magnitude of the response is insufficient," Moderbacher said. The scientists believe T cells, and helper T cells in particular, are associated with better protective immune responses. "This was perplexing to many people, but controlling a primary infection is not the same as vaccine-induced immunity, where the adaptive immune system is ready to pounce at time zero," Crotty said.

"Thus, these findings indicate it is plausible T cells are more important in natural SARS-CoV-2 infection, and antibodies more important in a COVID-19 vaccine," he said..


TRENDING

OPINION / BLOG / INTERVIEW

Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...

Videos

Latest News

FACTBOX-Latest on the worldwide spread of coronavirus

Britain re-imposed some lockdown measures as a second wave of coronavirus infections swept across Europe, while the death toll in the United States crossed 200,000, with a report saying the U.S. drug regulator would tighten COVID-19 vaccine...

Group sues Austrian gov't over ski resort virus outbreak

An Austrian consumer protection group said Wednesday it has filed four civil lawsuits against the countrys government for failing to contain a coronavirus outbreak at an Alpine ski resort during the early phase of the pandemic that has been...

DBT starts training program to strengthen clinical trial research capacity for neighbouring countries

The Department of Biotechnology, Government of India through the Ind-CEPI mission India Centric Epidemic Preparednessfor Rapid Vaccine Development and Supporting Indian Vaccine Development which is aligned with the Global Initiative of the ...

Soccer-Frank de Boer favourite to be named new Netherlands coach

Frank de Boer has emerged as the most likely candidate to be named coach of the Netherlands after weeks of speculation over who would succeed Ronald Koeman. A contract up to the 2022 World Cup finals in Qatar is expected to be signed in tim...

Give Feedback